Citation Analysis of Hepatitis Monthly by Journal Citation Report (ISI), Google Scholar, and Scopus. [electronic resource]
By: Contributor(s): Producer: 20121023Description: e7441 p. digitalISSN:- 1735-3408
Publication Type: Journal Article
There are no comments on this title.
-
1
Challenges facing microRNA therapeutics for cystic fibrosis lung disease.
by De Santi, Chiara -
2
Growth Stimulatory Effects and Genome-Wide Transcriptional Changes Produced by Protein Hydrolysates in Maize Seedlings.
by Santi, Chiara -
3
Nanomodulation of Macrophages in Multiple Sclerosis.
by Nally, Frances K -
4
Promotion of arsenic phytoextraction efficiency in the fern Pteris vittata by the inoculation of As-resistant bacteria: a soil bioremediation perspective.
by Lampis, Silvia -
5
Non-coding RNA in cystic fibrosis.
by Glasgow, Arlene M A -
6
Identification of a novel functional miR-143-5p recognition element in the Cystic Fibrosis Transmembrane Conductance Regulator 3'UTR.
by De Santi, Chiara -
7
CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease.
by Fernandez Fernandez, Elena -
8
Genome-Wide Transcriptional Changes and Lipid Profile Modifications Induced by Medicago truncatula N5 Overexpression at an Early Stage of the Symbiotic Interaction with Sinorhizobium meliloti.
by Santi, Chiara -
9
Alpha-1 antitrypsin augmentation therapy decreases miR-199a-5p, miR-598 and miR-320a expression in monocytes via inhibition of NFκB.
by Hassan, Tidi -
10
Expression of X-linked Toll-like receptor 4 signaling genes in female vs. male neonates.
by O'Driscoll, David N -
11
Identification of MiR-21-5p as a Functional Regulator of Mesothelin Expression Using MicroRNA Capture Affinity Coupled with Next Generation Sequencing.
by De Santi, Chiara -
12
Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.
by Fernández Fernández, Elena -
13
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people.
by Garritano, Sonia -
14
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma.
by Pellé, Lucia -
15
Expression status of candidate genes in mesothelioma tissues and cell lines.
by Melaiu, Ombretta -
16
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines.
by Melaiu, Ombretta -
17
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism.
by De Santi, Chiara -
18
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals.
by De Santi, Chiara -
19
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma.
by Cipollini, Monica -
20
Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24.
by Cipollini, Monica
Citation Analysis of Hepatitis Monthly by Journal Citation Report (ISI), Google Scholar, and Scopus.
APA
Miri S. M., Raoofi A. & Heidari Z. (20121023). Citation Analysis of Hepatitis Monthly by Journal Citation Report (ISI), Google Scholar, and Scopus. : Hepatitis monthly.
Chicago
Miri Seyyed Mohammad, Raoofi Azam and Heidari Zahra. 20121023. Citation Analysis of Hepatitis Monthly by Journal Citation Report (ISI), Google Scholar, and Scopus. : Hepatitis monthly.
Harvard
Miri S. M., Raoofi A. and Heidari Z. (20121023). Citation Analysis of Hepatitis Monthly by Journal Citation Report (ISI), Google Scholar, and Scopus. : Hepatitis monthly.
MLA
Miri Seyyed Mohammad, Raoofi Azam and Heidari Zahra. Citation Analysis of Hepatitis Monthly by Journal Citation Report (ISI), Google Scholar, and Scopus. : Hepatitis monthly. 20121023.